Cargando…

Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection

Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). We identified two candidate antigens (TcG2 and TcG4) that elicit antibodies and T cell responses in naturally infected diverse hosts. In this study, we cloned TcG2 and TcG4 in a nanovector and evaluated whether nano-immunotherapy (referred a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lokugamage, Nandadeva, Choudhuri, Subhadip, Davies, Carolina, Chowdhury, Imran Hussain, Garg, Nisha Jain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157635/ https://www.ncbi.nlm.nih.gov/pubmed/32098116 http://dx.doi.org/10.3390/vaccines8010096

Ejemplares similares

Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell Response
por: Chowdhury, Imran H., et al.
Publicado: (2020)

PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Origin of Monocytes/Macrophages Contributing to Chronic Inflammation in Chagas Disease: SIRT1 Inhibition of FAK-NFκB-Dependent Proliferation and Proinflammatory Activation of Macrophages
por: Wan, Xianxiu, et al.
Publicado: (2019)

Trypanosoma cruzi-specific CD8(+) T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research
por: Puerta, Concepción J., et al.
Publicado: (2023)

Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
por: Soprano, Luciana L., et al.
Publicado: (2023)

TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
por: Gupta, Shivali, et al.
Publicado: (2019)

Mitochondrial Regulation of Macrophage Response Against Pathogens
por: Choudhuri, Subhadip, et al.
Publicado: (2021)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
por: Teixeira, Antonio R. L., et al.
Publicado: (2011)

Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi
por: Meyers, Alyssa C., et al.
Publicado: (2020)

Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects
por: Deng, Xutao, et al.
Publicado: (2013)

Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy
por: Choudhuri, Subhadip, et al.
Publicado: (2021)

Lineage Analysis of Circulating Trypanosoma cruzi Parasites and Their Association with Clinical Forms of Chagas Disease in Bolivia
por: del Puerto, Ramona, et al.
Publicado: (2010)

Alteration of the aggregation and spatial organization of the vector of Chagas disease, Triatoma infestans, by the parasite Trypanosoma cruzi
por: Depickère, Stéphanie, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

The Parasite Load of Trypanosoma cruzi Modulates Feeding and Defecation Patterns of the Chagas Disease Vector Triatoma infestans
por: Chacón, Francisco, et al.
Publicado: (2022)

Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease
por: Lokugamage, Nandadeva, et al.
Publicado: (2021)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression
por: Gupta, Shivali, et al.
Publicado: (2015)

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
por: Chevillard, Christophe, et al.
Publicado: (2018)

The diversity of the Chagas parasite, Trypanosoma cruzi, infecting the main Central American vector, Triatoma dimidiata, from Mexico to Colombia
por: Dorn, Patricia L., et al.
Publicado: (2017)

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
por: Rodrigues-dos-Santos, Ícaro, et al.
Publicado: (2018)

Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease
por: Cai, Catherine W., et al.
Publicado: (2022)

Quantitative and histological assessment of maternal-fetal transmission of Trypanosoma cruzi in guinea pigs: An experimental model of congenital Chagas disease
por: Torres-Vargas, Jatziri, et al.
Publicado: (2018)

Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease
por: Mukherjee, Shankar, et al.
Publicado: (2011)

Métodos Diagnósticos para Trypanosoma cruzi en la enfermedad de Chagas : /
por: López Jiménez, Carlos Felipe
Publicado: (2015)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)

Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019)

Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador
por: Calvopina, Manuel, et al.
Publicado: (2020)

Trypanosoma cruzi parasitemia in chronic Chagas disease: Insights from hierarchical modeling
por: Abad-Franch, Fernando
Publicado: (2022)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_shsl9657qa40nohhitnk2476cu